KLK3 and prostate cancer: In contrast, these markers showed limited capacity in distinguishing tumour aggressiveness.<h4>Conclusions</h4>Systemic inflammatory indices are associated with prostate cancer presence and may enhance diagnostic performance when used alongside PSA.